Home › Trial NCT02077543
Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
- Trial IDNCT02077543
- StatusUnknown
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorUniversity Hospital, Grenoble
- Enrollment150
- Start date2013-10
- ConditionsGlioma : Oligodendroglioma or Astrocytoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.